2013
DOI: 10.1002/jat.2939
|View full text |Cite
|
Sign up to set email alerts
|

Prophylactic administration of non‐organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfone

Abstract: Poisoning with organophosphorus compounds (OPCs) poses a serious threat worldwide. OPC-induced mortality can be significantly reduced by prophylactic administration of reversible acetylcholinesterase (AChE) inhibitors. The only American Food and Drug Administration (FDA)-approved substance for such pre-treatment (to soman exposure) is presently pyridostigmine, although its efficacy is controversial. In search for more efficacious and broad-spectrum alternatives, we have assessed in vivo the mortality-reducing … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 64 publications
0
19
0
Order By: Relevance
“…Terbufos sulfone (TS) was administered i.p. at a dose of 100 nmol per rat (1/20 of LD 50 ) following our previous laboratory studies (13). The animals were treated daily for two weeks.…”
Section: Experimental Designmentioning
confidence: 99%
“…Terbufos sulfone (TS) was administered i.p. at a dose of 100 nmol per rat (1/20 of LD 50 ) following our previous laboratory studies (13). The animals were treated daily for two weeks.…”
Section: Experimental Designmentioning
confidence: 99%
“…This is followed by RR = 0.29 for tacrine, RR = 0.37 for pyridostigmine and RR = 0.62 for ranitidine. A comparison of these data with the results of previous studies during which the same AChE inhibitors were tested as prophylactic agents in the same experimental setting, but before exposure to chemically dissimilar OPCs (DFP, ethyl‐paraoxon, methyl‐paraoxon, terbufos sulfone) corroborates the assumption that the prophylactic efficacy varies, when different OPCs are administered (Lorke et al , ; Petroianu et al , ; Tuovinen et al , ). Reductions in RR observed for DFP exposure were, in ascending order: RR = 0.02 for physostigmine, RR = 0.05 for tacrine, RR = 0.18 for K‐27, RR = 0.28 for pyridostigmine and RR = 0.41 for ranitidine pre‐treatment (Lorke et al , ).…”
Section: Discussionmentioning
confidence: 99%
“…Given before methyl‐paraoxon (Lorke et al , ), only physostigmine (RR = 0.39), K‐27 (RR = 0.40) and tacrine (RR = 0.48) significantly reduced mortality; pyridostigmine and ranitidine had no significant effect. Terbufos sulfone‐induced mortality (Lorke et al , ) was reduced to RR = 0.06 by K‐27, to RR = 0.21 by tacrine, to RR = 0.28 by pyridostigmine, to RR = 0.29 by physostigmine and to RR = 0.33 by ranitidine. In spite of the variations in RR values and rankings observed for different AChE inhibitors, depending on the OPC administered, all these studies have in common that K‐27, physostigmine and tacrine are generally the three most efficacious prophylactic agents.…”
Section: Discussionmentioning
confidence: 99%
“…The most promising compound in this matter is the experimental oxime K-27, which is significantly more efficient than other tested cholinesterase inhibitors. 18) In the search of an AChE reversible inhibitor of the central nervous system, Huperzine A, a natural alkaloid, appears to have the greatest potential. However, this alkaloid is toxic at doses required for protection.…”
Section: Current Pretreatmentmentioning
confidence: 99%